CORRECTION: Aker Solutions ASA: Annual, Remuneration and Corporate Governance Reports for 2023
CORRECTION: Aker Solutions ASA: Annual, Remuneration and Corporate Governance Reports for 2023
PR Newswire
OSLO, Norway, March 20, 2024
OSLO, Norway, March 20, 2024 /PRNewswire/ -- Aker Solutions today publishes its annual report, remuneration report and corporate governance report for 2023. Correction: New versions of reports enclosed due to an incorrect file name of the file containing the annual financial statements in European Single Electronic Format (ESEF) published today at 07:02 CET.
CONTACT:
Preben Ørbeck
investor relations
preben.orbeck@akersolutions.com
+47 470 10 611
Hallvard Norum
media contact
hallvard.norum@akersolutions.com
+47 913 80 820
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
5967007LIEEXZXG42836-2023-12-31-en.zip | |
https://mb.cision.com/Public/18353/3948708/885c8cff84954d3c.pdf | Annual report 2023 |
https://mb.cision.com/Public/18353/3948708/844bed2c7b5d6a3f.pdf | Corporate Governance Report 2023 |
https://mb.cision.com/Public/18353/3948708/865b3ac0b52c16f5.pdf | Remuneration Report 2023 |
SOURCE Aker Solutions ASA
-
How the Tokyo Stock Exchange Is Pushing for Better Capital Allocation
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting